Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Craigbadon Dec 23, 2016 8:01am
142 Views
Post# 25639000

RE:RE:RE:James Hodgins of Curvature Hedge Strategies comments on PLI

RE:RE:RE:James Hodgins of Curvature Hedge Strategies comments on PLIAll these guys need to know is the cash burn, what management promised (cash flow positive by 2008), what they delivered and when they'll need cash again. I'm sure everyone wants to see them succeed by helping people and becoming a great Canadian pharma company but they'll still need to raise a huge amount of money to carry products accross the finish line and get products to market. If what people are saying about ownership of the warrants is true then they will likely need to do another market raise soon. Pretty easy for people like JH to cover their short by buying into the placement to get their replacement shares. That being said if they magically get a huge partnership deal in the next few weeks with an influx of cash and don't need to raise money everything changes fast. Everyone was waiting for Crh Medical to do a raise around the $5 level but when they didn't because they had significant cash flow, everyone had to buy open market, shorts and longs alike. Make no mistake, Pli will need money soon and the market knows it.

Aureus wrote: Pg as artificial plasma? Oh and we have FDA approval now? Another "smartM mamba BB Bidou" who knows d_ick about ProMetic!


Bullboard Posts